Another example concerns Murine Double Minute 2 (MDM2), an oncogene overexpressed in some mesothelioma tumours, which has been investigated as a therapeutic target in mesothelioma with wild-type p53 [129–131]. The gene discussed is TP53; the disease is mesothelioma.